Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Close this folder13. Partnership and collaboration
View the document13.1 The importance of supportive partners
View the document13.2 Possibilities at national, regional and international levels
Close this folder13.3 Various forms of collaboration
View the document13.3.1 Twinning arrangements
View the document13.3.2 Sharing information and resources
View the document13.3.3 Using established bulletins’ expertise
View the document13.3.4 Training sessions and workshops
View the document13.3.5 Ongoing information exchange between bulletins
View the document13.3.6 Collaborative research among bulletins
View the document13.3.7 Information and support for funding applications
View the document13.4 Identifying partners and networks
View the document13.5 Clearly define conditions for partnership
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

13.3.3 Using established bulletins’ expertise

There may also be situations where a new or small drug bulletin can develop its own articles, but where additional advice or the professional support of experts is needed. For example, it is useful to send drafts of articles for review to other bulletins that have recently produced articles on the same or a similar topic. An established bulletin may have contacts with medical experts in a specialised field you wish to write about. This kind of professional advice is most valuable. Some bulletins have great experience in retrieving and interpreting data from their regulatory agency and can help others to find evidence. In particular, members of staff from Public Citizen, USA, have shown other bulletin editors how to find information on the U.S. Food and Drug Administration web site.

Sometimes legal advice may be needed, especially if you expect a negative reaction from a critical article that may affect a company’s sales. You may find it helpful to obtain an opinion from a legal expert associated with another bulletin even if the legal situation in your country differs somewhat.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017